Aegis Spine, Inc., an innovative subsidiary of L&K BioMed, announces FDA 510(k) clearance of the new AccelFix Expandable Cage System

Aegis Spine, Inc., an innovative subsidiary of L&K BioMed, is proud and eager to announce FDA 510(k) clearance of the new AccelFix Expandable Cage System – a sterile-packaged, all-encompassing family of expandable interbody devices, which was launched this month at NASS 2019 in Chicago, Illinois.

The AccelFix Expandable Cage System includes expandable interbody solutions from TLIF/PLIF cages (AccelFix-XT), an expandable lateral interbody (AccelFix-XL), and a ground-breaking, Anterior-to-Psoas expandable interbody specially contoured to avoid the contralateral nerve root (Accelfix-XTP).

The launch of the new expandable interbody devices will be added to a wide range of spinal product portfolio which includes AccelFix 5.5 Rod Spinal Fixation System which earned a FDA clearance earlier this year.

AccelFix Email Signature Image 2

Next Up in Spinal Tech

Aegis Spine, Inc., an innovative subsidiary of L&K BioMed, announces FDA 510(k) clearance of the new AccelFix Expandable Cage System

Next Up in Spinal Tech

Xtant Medical finalizes spine transactions

Synergy Spine's cervical disc earns FDA approval

Zavation acquires ChoiceSpine

2026 Healthcare M&A Report: Inside the forces shaping healthcare consolidation

Next Up in Spinal Tech

Xtant Medical finalizes spine transactions

Synergy Spine's cervical disc earns FDA approval

Zavation acquires ChoiceSpine

Join the spine leaders & surgeons who start their day with Becker's